Trish Shucoski Named BayCare’s Incoming Chief Nurse Executive

BayCare announced today that Patricia “Trish” Shucoski, DNP, MSN, RN, NEA-BC, will be its next Chief Nurse Executive (CNE), leading a corps of more than 10,550 nurses and nursing support staff when she assumes the role in December.

Shucoski is a nurse with nearly 20 years of experience as a health care leader and holds a doctorate in nursing practice. A Florida licensed nurse, she is currently BayCare’s vice president of customer access and operational excellence and is succeeding CNE Lisa Johnson, who is retiring after more than a 35-year career with BayCare.

“BayCare’s nurses and our patients deserve the very best in a leader and we are excited to have Trish take this role,” said CEO and President Stephanie Conners. “Her experience supporting patient care delivery will ensure that BayCare’s nurses remain at the forefront in the industry in best practice and compassionate care.”

Prior to joining BayCare, Shucoski worked for Jefferson Health in Philadelphia as its senior vice president for performance excellence and system integration. Before that, she worked as Cooper University Hospital’s associate vice president of patient care services for four years and its executive director of hospital-based services for three years. As a registered nurse in New Jersey and Pennsylvania, Trish worked for both Cancer Treatment Centers of America, where she was chief nurse, and Hahnemann University Hospital/Tenet Healthcare.

She earned a Doctor of Nursing practice/healthcare systems leadership from Chamberlain University; a Master of Science in nursing, leadership/nursing management from Drexel University, and a bachelor’s degree in nursing from Villanova University. Additionally, Trish holds two associate degrees, one from the State University of New York at Farmingdale (SUNY Farmingdale) in allied health and science/nursing and one in science from Nassau Community College.

Shucoski resides with her husband and two children in Largo. She will assume the CNE role on Dec. 11.

Hot this week

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.